Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Exercise
Calculated transaction value
$0

Rothblatt Martine A Chairperson & CEO

Transaction date Jul 28, 2026
Public filing date Jul 28, 2026
Filing lag Filed same day

UTHR daily price context

Close on/before transaction
$523.63 Jul 28, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Derivative
Security
Stock Option on Common Stock
Quantity / price
9,500 shares @ $0
SEC ownership
Indirect
Transaction code
M
Form
4
Filing identifier
0001106578-26-000108
Filing cohort

Transactions in this filing

Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$6.29M
Buys / sales
0 / 10
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Sale Jul 28, 2026 $721.68K
United Therapeutics Corp UTHR Current Exercise Jul 28, 2026 $0
United Therapeutics Corp UTHR Sale Jul 28, 2026 $330.88K
United Therapeutics Corp UTHR Sale Jul 28, 2026 $715.15K
United Therapeutics Corp UTHR Exercise Jul 28, 2026 $1.29M
United Therapeutics Corp UTHR Sale Jul 28, 2026 $21.3K
United Therapeutics Corp UTHR Sale Jul 28, 2026 $606.9K
United Therapeutics Corp UTHR Sale Jul 28, 2026 $213.98K
United Therapeutics Corp UTHR Sale Jul 28, 2026 $775.29K
United Therapeutics Corp UTHR Sale Jul 28, 2026 $459.92K
United Therapeutics Corp UTHR Sale Jul 28, 2026 $596.05K
United Therapeutics Corp UTHR Sale Jul 28, 2026 $562.82K